You've just started your job with a small biotech startup that has some promising drug candidates and a freewheeling culture. You enjoy the shorts and T-shirt dress code and the midnight pizza parties for late workers, as well as the generous stock options. But then it's announced that your company has sold a large equity stake to a mega-pharmaceutical company. Now you're expected to wear a suit when meeting with your partners. To make matters worse, the large equity stake the pharma company bought has diluted your own shares. Things just aren't quite as interesting as they used to be.
That's the best-case scenario for a biotech employee. Far worse is the prospect of an outright merger with a pharmaceutical giant, which might result in the loss of your job. The good news for those who enjoy working in the biotech industry is that the number of biotech-Big Pharma marriages ...
